ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Boron Difluoride Formazanate Dye With Donor Planarization Engineering for 1060 nm Laser Activated Photothermal Theranostics.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Engineering Nanoemulsions to Maximize NIR-II Fluorescence and Preserve Photothermal Performance of a Novel Boron Difluoride Formazanate Dye.Angewandte Chemie (International ed. in English) · 2026Article
- Nanotechnology-enabled precision strategies for bladder cancer: from in vitro diagnostics to in vivo therapy.Journal of nanobiotechnology · 2026Review
- Boron Difluoride Formazanate Dye With Donor Planarization Engineering for 1060 nm Laser Activated Photothermal Theranostics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Phototheranostics within the second near-infrared (NIR-II, 1000-1700 nm) window offer considerable advantages compared to those operating in the visible and first near-infrared region (NIR-I, 700-900 nm). Herein, a donor-acceptor-donor (D-A-D) structured NIR-II absorbing Boron Difluoride Formazanate (BDF) dye FBDFDPA is developed through a donor engineering strategy for 1060 nm laser-excited photoacoustic imaging (PAI)-guided photothermal therapy (PTT). By replacing the donor unit from alkoxy-substituted triphenylamine with alkoxy-substituted diphenylamine, the planarity of the molecular conjugated skeleton is enhanced, thus promoting the intramolecular charge transfer (ICT) effect, leading to a 138 nm redshift in absorption and extending it into the NIR-II region. FBDFDPA NPs show excellent molar extinction coefficient (ε = 7.66 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.